Rezolute, Inc. (RZLT)
4.595
+0.04
(+0.77%)
USD |
NASDAQ |
Sep 03, 11:43
Rezolute Cash from Investing (Quarterly) : 12.28M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 12.28M |
| December 31, 2025 | 22.81M |
| September 30, 2025 | -68.49M |
| June 30, 2025 | 0.346M |
| March 31, 2025 | 23.05M |
| December 31, 2024 | 11.47M |
| September 30, 2024 | -49.41M |
| June 30, 2024 | 19.66M |
| March 31, 2024 | 8.67M |
| December 31, 2023 | 17.76M |
| September 30, 2023 | 2.606M |
| June 30, 2023 | -6.357M |
| March 31, 2023 | -94.95M |
| December 31, 2022 | -0.083M |
| September 30, 2022 | -0.07M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.0066M |
| March 31, 2019 | 0.0425M |
| December 31, 2018 | 0.008M |
| September 30, 2018 | 0.1871M |
| June 30, 2018 | 1.55M |
| March 31, 2018 | 0.1875M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.0058M |
| June 30, 2017 | -0.0826M |
| March 31, 2017 | -0.0277M |
| December 31, 2016 | -0.0241M |
| September 30, 2016 | -0.061M |
| June 30, 2016 | -0.3174M |
| March 31, 2016 | -0.5169M |
| December 31, 2015 | -0.6812M |
| September 30, 2015 | -0.3889M |
| June 30, 2015 | -2.233M |
| March 31, 2015 | -1.059M |
| December 31, 2014 | -0.153M |
| September 30, 2014 | -0.168M |
| June 30, 2014 | -0.82M |
| March 31, 2014 | -0.0034M |
| December 31, 2013 | -0.0034M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 0.00 |
| AbbVie, Inc. | -1.197B |
| Marker Therapeutics, Inc. | 0.00 |
| Avalo Therapeutics, Inc. | -329.92M |
| Krystal Biotech, Inc. | -161.58M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.74M |
| Cash from Financing (Quarterly) | 0.747M |
| Free Cash Flow | -73.48M |
| Free Cash Flow Per Share (Quarterly) | -0.132 |
| Free Cash Flow to Equity (Quarterly) | -13.56M |
| Free Cash Flow to Firm (Quarterly) | -13.74M |
| Free Cash Flow Yield | -15.78% |